Eriong Lee‐Vergés

CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemia

Arnau Montraveta, Eriong Lee‐Vergés, Jocabed Roldán et al. · Oncotarget · 2015 · 36 citations · Full text

Medicine, Oncology, Pharmacology +16

Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells

Mònica López‐Guerra, Sílvia Xargay‐Torrent, Patricia Fuentes et al. · Oncogene · 2019 · 33 citations · Full text

Medicine, Hematology, Oncology +12

Human organic cation transporter 1 (hOCT1) as a mediator of bendamustine uptake and cytotoxicity in chronic lymphocytic leukemia (CLL) cells

Cristina Arimany-Nardí, Arnau Montraveta, Eriong Lee‐Vergés et al. · The Pharmacogenomics Journal · 2015 · 18 citations · Full text

Medicine, Oncology, Pharmacology +15

Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia

Eriong Lee‐Vergés, Bola S. Hanna, Haniyeh Yazdanparast et al. · International Journal of Cancer · 2018 · 12 citations · Full text

Medicine, Oncology, Pharmacology +17

Bcl-2<i>high</i>mantle cell lymphoma cells are sensitized to acadesine with ABT-199

Arnau Montraveta, Sílvia Xargay‐Torrent, Laia Rosich et al. · Oncotarget · 2015 · 10 citations · Full text

Medicine, Hematology, Oncology +12